Discounted Cash Flow
Zimmer Biomet Holdings, Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $7.7b | $305.9m | $1.4b | 4.0% | $1.53 |
| 2017 | $7.8b (1.8%) | $1.8b (492.9%) | $1.4b (-1.5%) | 23.2% (482.3%) | $8.98 (486.9%) |
| 2018 | $7.9b (1.4%) | $-379.2m (-120.9%) | $1.6b (11.1%) | -4.8% (-120.6%) | $-1.86 (-120.7%) |
| 2019 | $8.0b (0.6%) | $1.1b (398.4%) | $1.4b (-13.0%) | 14.2% (396.6%) | $5.52 (396.8%) |
| 2020 | $7.0b (-12.0%) | $-138.9m (-112.3%) | $1.1b (-21.2%) | -2.0% (-113.9%) | $-0.67 (-112.1%) |
| 2021 | $7.8b (11.6%) | $401.6m (389.1%) | $1.3b (22.1%) | 5.1% (359.2%) | $1.93 (388.1%) |
| 2022 | $6.9b (-11.4%) | $231.4m (-42.4%) | $-259.4m (-119.5%) | 3.3% (-34.9%) | $1.10 (-43.0%) |
| 2023 | $7.4b (6.5%) | $1.0b (342.5%) | $-291.1m (-12.2%) | 13.8% (315.3%) | $4.91 (346.4%) |
| 2024 | $7.7b (3.8%) | $903.8m (-11.7%) | $1.3b (545.1%) | 11.8% (-15.0%) | $4.45 (-9.4%) |
| 2025 | $8.2b (7.2%) | $705.1m (-22.0%) | $1.5b (13.7%) | 8.6% (-27.2%) | $3.56 (-20.0%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Values abbreviated: b = billions, m = millions, k = thousands.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.